# Invesco CurrencyShares Canadian Dollar Trust: overview

FXC · NYSE · CIK 1353612 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fxc.md) · [Financials](/companies/fxc/financials.md) · [Filings](/companies/fxc/filings.md) · [Insiders](/companies/fxc/insiders.md)

Latest reported revenue: [$98.8k](/filings/0001193125-26-338711.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-338711).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [362](/filings/0001193125-25-270329.md) | [271 d](/filings/0001193125-26-083543.md) | [189](/filings/0001193125-26-209777.md) | [195](/filings/0001193125-26-338711.md) | [209](/filings/0001193125-25-270329.md) | [121 d](/filings/0001193125-26-083543.md) | [104](/filings/0001193125-26-209777.md) | [98.8](/filings/0001193125-26-338711.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [82.9%](/filings/0001193125-25-270329.md) | [77.1% d](/filings/0001193125-26-083543.md) | [64.9%](/filings/0001193125-26-209777.md) | [56.6%](/filings/0001193125-26-338711.md) | [55.3%](/filings/0001193125-25-270329.md) | [31.9% d](/filings/0001193125-26-083543.md) | [22.6%](/filings/0001193125-26-209777.md) | [22.6%](/filings/0001193125-26-338711.md) |
| Diluted EPS | $ per share | [0.35](/filings/0001193125-25-270329.md) | not reported | [0.12](/filings/0001193125-26-209777.md) | [0.09](/filings/0001193125-26-338711.md) | [0.09](/filings/0001193125-25-270329.md) | not reported | [0.02](/filings/0001193125-26-209777.md) | [0.02](/filings/0001193125-26-338711.md) |
| Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [0.0](/filings/0000950170-23-004222.md) | [613](/filings/0000950170-24-019058.md) | [2,223](/filings/0000950170-25-027265.md) | [1,493](/filings/0001193125-26-083543.md) | [714](/filings/0001193125-26-083543.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | [23.9%](/filings/0000950170-24-019058.md) | [84.1%](/filings/0000950170-25-027265.md) | [83.4%](/filings/0001193125-26-083543.md) | [54.2%](/filings/0001193125-26-083543.md) |
| Diluted EPS | $ per share | [(0.31)](/filings/0000950170-23-004222.md) | [0.09](/filings/0000950170-24-019058.md) | [1.54](/filings/0000950170-25-027265.md) | [1.43](/filings/0001193125-26-083543.md) | [0.33](/filings/0001193125-26-083543.md) |
| Free cash flow | $k | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fxc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $11.5m | 167,373 |  | Added +84,014 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $5.4m | 77,800 | Call | Added +16,300 |
| [Ashton Thomas Private Wealth, LLC](/funds/2019663.md) | 2026-06-30 | $3.0m | 44,015 |  | Added +9,701 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $1.2m | 17,600 | Put | Reduced −12,700 |
| [ROYAL BANK OF CANADA](/funds/1000275.md) | 2026-06-30 | $943.0k | 13,678 |  | Added +736 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $765.1k | 11,100 | Call | Reduced −12,500 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $765.1k | 11,100 | Put | New +11,100 |
| [WELLS FARGO & COMPANY/MN](/funds/72971.md) | 2026-06-30 | $705.9k | 10,241 |  | Reduced −333 |
| [Unconventional Investor, LLC](/funds/1910387.md) | 2026-06-30 | $493.4k | 7,158 |  | Added +2 |
| [3EDGE Asset Management, LP](/funds/1665605.md) | 2026-06-30 | $473.8k | 6,874 |  | Unchanged |

## Recent filings

[All 172 filings](/companies/fxc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 20:05 ET | [8-K](/filings/0001193125-26-427817.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-427817 |
| 2026-08-07 | 23:26 ET | [10-Q](/filings/0001193125-26-338711.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338711 |
| 2026-08-03 | 20:05 ET | [8-K](/filings/0001193125-26-330546.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-330546 |
| 2026-06-08 | 21:31 ET | [8-K](/filings/0001193125-26-260000.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-260000 |
| 2026-05-07 | 00:23 ET | [10-Q](/filings/0001193125-26-209777.md) | Quarterly report, period 2026-03-31 | 0001193125-26-209777 |
| 2026-03-02 | 23:44 ET | [10-K](/filings/0001193125-26-083543.md) | Annual report, period 2025-12-31 | 0001193125-26-083543 |
| 2025-11-07 | 00:08 ET | [10-Q](/filings/0001193125-25-270329.md) | Quarterly report, period 2025-09-30 | 0001193125-25-270329 |
| 2025-08-07 | 20:41 ET | [10-Q](/filings/0000950170-25-105143.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105143 |
| 2025-05-08 | 21:12 ET | [10-Q](/filings/0000950170-25-067204.md) | Quarterly report, period 2025-03-31 | 0000950170-25-067204 |
| 2025-02-26 | 02:39 ET | [10-K](/filings/0000950170-25-027265.md) | Annual report, period 2024-12-31 | 0000950170-25-027265 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-083543.md), filed Mar 2, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/c587f19d-3a1c-4bfa-a062-5706bbea3670)

## About the filer

- CIK: 1353612
- Tickers: FXC
- Exchange: NYSE
- SIC code: 6221 Commodity Contracts Brokers & Dealers
- State of incorporation: NY
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.